Liquid Biopsy Industry 2019 Global Pipeline Review Analysis and Outlook 2026

WiseGuyReports.Com Publish a New Market Research Report On –“ Liquid Biopsy 2019 Market Research and Development, Future Outlook Analysis to 2026”.

Liquid Biopsy Industry 2019

Description:-

The global liquid biopsy market is anticipated to reach USD 3,051.1 million by 2025. In 2017, by biomarker type, Circulating Tumor Cells (CTC) segment was observed to capture the largest market share in terms of revenue. Regionally, North America liquid biopsy market accounted for the majority share.

Liquid Biopsy can be described as a traditional technique that is used in diagnosis of cancer at an early stage. It is also known as fluid biopsy or fluid phase biopsy. It is largely a non-invasive technique, which helps in proper tracking of tumors and mutations over a duration of time. Usage of these provides doctors with a range of information about the tumor’s future. Despite being a revolutionary technique, liquid biopsy has multiple challenges in terms of adoption over tissue biopsy.

 

Get a Free Sample Report @    https://www.wiseguyreports.com/sample-request/3695829-liquid-biopsy-market-by-technology-single-gene-analysis

For more information or any query mail at sales@wiseguyreports.com

 

The liquid biopsy market is primarily driven by the increasing cases of patients being detected with various types of cancer. Also, considering number of free trails coupled with rising demand for liquid biopsy with minimal invasive surgeries is expected to enhance the market growth during forecast period. Also, liquid biopsy is observed to be the fastest emerging substitute for tissue biopsy due to reduced number of surgical invasions. Furthermore, increasing trend of strategic mergers and acquisitions by key players to support their focus on continuous research and development activities also positively impacts the liquid biopsy market.

On the basis of technology type, the report on global liquid biopsy market covers single gene analysis (PCR Microarrays), and multi-gene-parallel analysis (NGS). NGS multiplex testing helps in diagnosis of multiple diseases at a single time, while PCR helps in analyzing the mutation among genes. Based on sample type, the global liquid biopsy market is sub-segmented into blood, urine, saliva, and other body fluid. Blood sample is the most common sample type that is used by doctors for proper analysis as blood contains cell free DNA, circulating cell, and exosomes that can be detected easily eventually helping in easy diagnosis of the cancer cell in the human body. Moreover, saliva and other body fluids are other sampling types in this market which have significant market share.

Based on the biomarker type, the global liquid biopsy market is further segmented into exosomes, Circulating Tumor Cells (CTC), and Circulating tumor DNA (ctDNA). CTC biomarker is expected hold the largest market share owing to its high awareness, and effective results for tracking the cancer cells in human body. In addition, it facilitates early detection of cells which in turn helps for appropriate diagnosis and clinical decisions related to detected cancer in the initial stage itself.

The global liquid biopsy market report covers molecular health monitoring, therapy selection for other meta cancer, and therapy selection for MBS applications. Various therapy for treating meta cancer application is observed to hold major market share owing to the rising number of metastatic cancer incidences, and rising number of therapies for its treatment. Additionally, increase in treatment commercialization for metastatic cancers to also drive growth in this market.

North America region is observed to hold the dominating position as per geography in the liquid biopsy market during the forecast period. Factors such as increasing advanced accessibility for the diagnosis of cancer, and increasing number of patients suffering from cancer promote the growth of this market. Meanwhile, Asia Pacific is supposed to grow at a faster rate during the forecast period.

The major players operating in the liquid biopsy market include Roche Diagnostics, Illumina, Inc., Bio-Rad Laboratories Inc., Myriad Genetics, Inc., Menarini Silicon Biosystems, Genomic Health, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Biocept, Inc., Trovagene, Inc., RainDance Technologies, Inc., Guardant Health, Inc., and MDx Health SA.

 

Enquiry About Report @  https://www.wiseguyreports.com/enquiry/3695829-liquid-biopsy-market-by-technology-single-gene-analysis

 

Table Of Contents – Major Key Points

  1. Overview and Scope
    1.1. Research goal & scope
    1.2. Research assumptions
    1.3. Research methodology
    1.3.1. Primary data sources
    1.3.2. Secondary data sources
    1.4. Key take-away
    1.5. Stakeholders
  2. Executive Summary
    2.1. Market definition
    2.2. Market segmentation
  3. Liquid Biopsy Market Insights
    3.1. Liquid Biopsy– Industry snapshot
    3.2. Leading Companies
    3.3. Key Companies to Watch
    3.4. Liquid Biopsy- Ecosystem analysis
    3.5. Disease overview
    3.6. Commercial Landscape
    3.7. Liquid Biopsy market Dynamics
    3.7.1. Liquid Biopsy– Market Forces
    3.7.2. Liquid Biopsy Market Driver Analysis
    3.7.3. Liquid Biopsy Market Restraint/Challenges analysis
    3.7.4. Liquid Biopsy market Opportunity Analysis
    3.8. Industry analysis – Porter’s five forces
    3.8.1. Bargaining power of supplier
    3.8.2. Bargaining power of buyer
    3.8.3. Threat of substitute
    3.8.4. Threat of new entrant
    3.9. Degree of competition
    3.10. Liquid Biopsy market PEST Analysis, 2017
    3.11. Liquid Biopsy Market Value Chain Analysis
    3.12. Liquid Biopsy Industry Trends
    3.13. Competitive Ranking Analysis
  4. Liquid Biopsy Market Size and Forecast, 2017-2025 by Technology Types
    4.1. Key Findings
    4.2. Single Gene Analysis (PCR Microarrays)
    4.2.1. Global market estimates and forecasts, 2017 – 2025
    4.3. Multi-gene-parallel analysis (NGS)
    4.3.1. Global market estimates and forecasts, 2017 – 2025
  5. Liquid Biopsy Market Size and Forecast, 2017-2025 by Sample type
    5.1. Key Findings
    5.2. Blood
    5.2.1. Global market estimates and forecasts, 2017 – 2025
    5.3. Urine
    5.3.1. Global market estimates and forecasts, 2017 – 2025
    5.4. Saliva
    5.4.1. Global market estimates and forecasts, 2017 – 2025
    5.5. Other Body Fluids
    5.5.1. Global market estimates and forecasts, 2017 – 2025

Continued……

Buy 1-user PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3695829

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

http://www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

ABOUT US:

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Liquid Biopsy Market Research Report 2017 Global Analysis and Forecast to 2022

WiseGuyReports.Com Publish a New Market Research Report On – Liquid Biopsy Market Research Report 2017 Global Analysis and Forecast to 2022”.

 

This report studies the global Liquid Biopsy market, analyzes and researches the Liquid Biopsy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
RainDance Technologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc

 

Get a Sample Report @   https://www.wiseguyreports.com/sample-request/1139151-global-liquid-biopsy-market-size-status-and-forecast-2022

For more information or any query mail at sales@wiseguyreports.com
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Liquid Biopsy can be split into
CTC
ctDNA
Exosomes

Market segment by Application, Liquid Biopsy can be split into
Blood Sample
Urine Sample
Other Bio Fluids

If you have any special requirements, please let us know and we will offer you the report as you want.

 

Ask Query @  https://www.wiseguyreports.com/enquiry/1139151-global-liquid-biopsy-market-size-status-and-forecast-2022

 

Table Of Contents – Major Key Points

Global Liquid Biopsy Market Size, Status and Forecast 2022
1 Industry Overview of Liquid Biopsy
1.1 Liquid Biopsy Market Overview
1.1.1 Liquid Biopsy Product Scope
1.1.2 Market Status and Outlook
1.2 Global Liquid Biopsy Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Liquid Biopsy Market by Type
1.3.1 CTC
1.3.2 ctDNA
1.3.3 Exosomes
1.4 Liquid Biopsy Market by End Users/Application
1.4.1 Blood Sample
1.4.2 Urine Sample
1.4.3 Other Bio Fluids

2 Global Liquid Biopsy Competition Analysis by Players
2.1 Liquid Biopsy Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 RainDance Technologies
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Liquid Biopsy Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Biocartis
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Liquid Biopsy Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Qiagen
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Liquid Biopsy Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Guardant Health
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Liquid Biopsy Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 MDxHealth
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Liquid Biopsy Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Pathway Genomics
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Liquid Biopsy Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 NeoGenomics Laboraories
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Liquid Biopsy Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Sysmex Inostics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Liquid Biopsy Revenue (Value) (2012-2017)
3.8.5 Recent Developments

Continue…….

For more information or any query mail at sales@wiseguyreports.com

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

http://www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

ABOUT US:

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

 

Liquid Biopsy 2017 Global Market Outlook,Research,Trends and Forecast to 2022

WiseGuyReports.Com Publish a New Market Research Report On – Liquid Biopsy 2017 Global Market Outlook,Research,Trends and Forecast to 2022”.

 

Global Liquid Biopsy market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Biocept, Inc.
Qiagen N.V.
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini-Silicon Biosystems
Trovagene
Guardant Health
Mdxhealth
Genomic Health
Raindance Technologies
Thermo Fisher Scientific
Illumina 

 

Get a Sample Report @   https://www.wiseguyreports.com/sample-request/2355704-global-liquid-biopsy-market-research-report-2017

For more information or any query mail at sales@wiseguyreports.com

 

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Liquid Biopsy in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Assays Kits
Instruments
Services

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Liquid Biopsy for each application, including
Reference Laboratories?
Hospitals and Physician Laboratories
Academic and Research Centers
Other End Users

 

Ask Query @  https://www.wiseguyreports.com/enquiry/2355704-global-liquid-biopsy-market-research-report-2017

 

Table Of Contents – Major Key Points

 

Global Liquid Biopsy Market Research Report 2017
1 Liquid Biopsy Market Overview
1.1 Product Overview and Scope of Liquid Biopsy
1.2 Liquid Biopsy Segment by Type (Product Category)
1.2.1 Global Liquid Biopsy Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Liquid Biopsy Production Market Share by Type (Product Category) in 2016
1.2.3 Assays Kits
1.2.4 Instruments
1.2.5 Services
1.3 Global Liquid Biopsy Segment by Application
1.3.1 Liquid Biopsy Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Reference Laboratories?
1.3.3 Hospitals and Physician Laboratories
1.3.4 Academic and Research Centers
1.3.5 Other End Users
1.4 Global Liquid Biopsy Market by Region (2012-2022)
1.4.1 Global Liquid Biopsy Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Liquid Biopsy (2012-2022)
1.5.1 Global Liquid Biopsy Revenue Status and Outlook (2012-2022)
1.5.2 Global Liquid Biopsy Capacity, Production Status and Outlook (2012-2022)

2 Global Liquid Biopsy Market Competition by Manufacturers
2.1 Global Liquid Biopsy Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Liquid Biopsy Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Liquid Biopsy Production and Share by Manufacturers (2012-2017)
2.2 Global Liquid Biopsy Revenue and Share by Manufacturers (2012-2017)
2.3 Global Liquid Biopsy Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Liquid Biopsy Manufacturing Base Distribution, Sales Area and Product Type
2.5 Liquid Biopsy Market Competitive Situation and Trends
2.5.1 Liquid Biopsy Market Concentration Rate
2.5.2 Liquid Biopsy Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

……..

7 Global Liquid Biopsy Manufacturers Profiles/Analysis
7.1 Biocept, Inc.
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Liquid Biopsy Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Biocept, Inc. Liquid Biopsy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Qiagen N.V.
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Liquid Biopsy Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Qiagen N.V. Liquid Biopsy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Roche Diagnostics
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Liquid Biopsy Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Roche Diagnostics Liquid Biopsy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Bio-Rad Laboratories
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Liquid Biopsy Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Bio-Rad Laboratories Liquid Biopsy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Myriad Genetics
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Liquid Biopsy Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Myriad Genetics Liquid Biopsy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Menarini-Silicon Biosystems
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Liquid Biopsy Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Menarini-Silicon Biosystems Liquid Biopsy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Trovagene
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Liquid Biopsy Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Trovagene Liquid Biopsy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Guardant Health
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Liquid Biopsy Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Guardant Health Liquid Biopsy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview

Continue…….

 

For more information or any query mail at sales@wiseguyreports.com

Buy 1-User PDF@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2355704

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

http://www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

ABOUT US:

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.